Home » Topics » BioWorld Science

BioWorld Science
RSS

Antisense oligonucleotides inhibit nonsense-mediated RNA decay in W1282X cystic fibrosis

Nov. 8, 2019

Study identifies metabolic path from stress to anxiety

Nov. 8, 2019

New inhibitor blocks, degrades MYC

Nov. 8, 2019

CARB-X grant supports Techulon's development of new class of antimicrobial

Nov. 7, 2019

ObsEva to discontinue nolasiban IVF program after phase III trial misses primary endpoint

Nov. 7, 2019

Hungarian scientists patent myosin-2 ATPase activity inhibitors

Nov. 7, 2019

Chinese researchers present new p300 HAT inhibitors

Nov. 7, 2019

VTCN1 gene linked to schizophrenia in Chinese families

Nov. 7, 2019

Thomas Helledays Stiftelse foer Medicinsk Forskning divulges MTHFD2 inhibitors

Nov. 7, 2019

U.K. researchers patent BCL-6 inhibitors

Nov. 7, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...